MedTrace Logo

Neuro-orthopaedic Surgery in the Treatment of the Spastic Equinovarus Foot

NCT01265238 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2015-01-01

No results posted yet for this study

Summary

Spastic equinovarus foot (SEF) is a major cause of disability in stroke patients. Treatments may include physical therapy, orthosis, botulinum toxin (BTX) injections, selective tibial neurotomy and tendon lengthening and/or transfer.

Until now, no study has been conducted to assess the result of neuro-orthopaedic surgery in the treatment of SEF.

The aim of this study is to evaluate the benefit of neuro-orthopaedic surgery (selective neurotomy and/or Achilles tendon lengthening and/or tibialis anterior transfer) in case of SEF according to the 3 domains of the International Classification of Functioning, Disability and Health (ICF)of the World Health organisation (WHO)

Conditions

  • Spasticity
  • Spastic Foot
  • Stroke

Sponsors & Collaborators

  • University Hospital of Mont-Godinne

    lead OTHER

Principal Investigators

  • Thierry M Deltombe, M.D. · University Hospital of Mont-Godinne, Université Catholique de Louvain

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-03-31
Completion
2014-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01265238 on ClinicalTrials.gov